Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Glenn Jaffe, MD
Duke University Eye Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Augenarzte Am St. Franziskus Hospital
Münster, Germany
- Universitatsklinikum Tubingen
Tübingen, Germany
- Bajcsy-Zsilinszky Kórház És Rendelőintézet
Budapest, Hungary
- L. V. Prasad Eye Institute - Hospital
Hyderabad, Andhra Pradesh, India
- L.V. Prasad Eye Institute
Patia, Bhubaneshwar, India
- C.H Nagri Municipal Eye Hospital
Ahmedabad, Gujarat, India
- Seth G.S. Medical College & Kem Hospital
Pārel, Mumbai, India
- Pbma'S H.V. Desai Eye Hospital
Hadapsar, Pune, India
- King George'S Medical University
Lucknow, Uttar Pradesh, India
- Hadassah University Hospital Ein Kerem
Jerusalem, Israel
- Rabin Medical Center
Petah Tikva, Israel
- Sheba Medical Center
Qiryat Ono, Israel
- Royal Hospitals Trust
Belfast, United Kingdom
- Birmingham and Midland Eye Centre
Birmingham, United Kingdom
- Bradford Royal Infirmary
Bradford, United Kingdom
- Gloucestershire Royal Hospital
Gloucester, United Kingdom
- Moorfields Eye Hospital
London, United Kingdom
- St Thomas Hospital
London, United Kingdom
- Retina Vitreaous Associates
Beverly Hills, California, United States
- Retinal Consultants Medical Group, Inc
Sacramento, California, United States
- Retina Macula Institute
Torrance, California, United States
- Retina Consultants of Southern Colorado
Colorado Springs, Colorado, United States
- Northwestern University
Chicago, Illinois, United States
- Ophthalmology & Visual Sciences
Lexington, Kentucky, United States
- Ocular Immunology and Uveitis Foundation
Cambridge, Massachusetts, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Retina Consultants
Slingerlands, New York, United States
- Duke University Eye Center
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohsu Casey Eye Institute
Portland, Oregon, United States
- Charleston Neuroscience Institute
Ladson, South Carolina, United States
- Texas Retina Associates
Arlington, Texas, United States
- Retina Consultants of Houston
Houston, Texas, United States
- Foresight Studies, Llc
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Aug 2013
- Primary completion
- 26 Mar 2018
- Completion
- 26 Mar 2018
- Last update posted
- 2 Apr 2021
- Registered enrollment
- 129
- Registry id
- NCT01694186
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.